Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cannabidiol Reduces Seizures in Dravet Syndrome

Publish date:: June 25, 2019

Key clinical point: Adjunctive CBD reduces the rate of convulsive seizures in patients with Dravet syndrome.

Major finding: The 10-mg/kg per day dose reduced the rate of convulsive seizures by 49%.

Study details: A prospective, randomized, placebo-controlled study of 199 children with Dravet syndrome.

Disclosures: GW Research supported the study. Dr. Miller has received compensation and research support from several companies, including GW Pharma.

Citation:

Miller I et al. AAN 2019, Abstract P3.6-076.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Epilepsy & Seizures

Study supports halting antiseizure medications after neonatal seizures,

CBD for LGS: Fewer seizures, but thrombocytopenia risk,

Preventive treatment delays first seizure onset in tuberous sclerosis complex,

Listening to Mozart helps tame epilepsy,

In epilepsy, brain-responsive stimulation passes long-term tests,